FTC-Amgen Deal: 'Major Advance,' Or 'Narrow Assurance'?
By Bryan Koenig · September 6, 2023, 5:56 PM EDT
The Federal Trade Commission and Amgen have very different takes on what their settlement allowing the company to complete its $27.8 billion purchase of Horizon Therapeutics signals for the agency's ability...
To view the full article, register now.